IP Library Granted Patent US 7,807,813
Granted Patent B2
US 7,807,813 · App. 11/584,252 · Granted Oct 5, 2010

Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,813
App. No.
11/584,252
Granted
Oct 5, 2010
Kind
B2
Abstract

West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.

Claims (11)

1. A kit for detecting the presence of WNV in a biological sample, the kit comprising a pair of amplification primers and an internal control sequence, said pair of amplification primers comprising a sense primer and an antisense primer wherein each of the primers is an oligonucleotide of not more than about 60 nucleotides in length and is sufficiently complementary to a portion of the antisense and sense strands, respectively, of WNV nucleic acids and to hybridize therewith and to allow amplification of said WNV nucleic acids, wherein said internal control sequence comprises the nucleotide sequence of SEQ ID NO:17 and is capable of amplification by said pair of amplification primers.

2. The kit of claim 1 , wherein the sense primer comprises SEQ ID NO:34 or a nucleotide sequence having at least 90% sequence identity thereto, and wherein the antisense primer comprises SEQ ID NO:35 or a nucleotide sequence having at least 90% sequence identity thereto.

3. The kit of claim 2 , further comprising a polymerase and buffers.

4. The kit of claim 2 , further comprising at least one probe oligonucleotide of not more than about 60 nucleotides in length and comprises the sequence of SEQ ID NO:52 or the sequence of SEQ ID NO:53, wherein the probe selectively binds to WNV nucleic acids.

5. The kit of claim 4 , wherein the probe further comprises detectable labels at the 5′-end and at the 3′-end.

6. The kit of claim 5 , wherein the detectable label is a fluorescent label selected from the group consisting of 6-carboxyfluorescein (6-FAM), tetramethyl rhodamine (TAMPA), and 2′,4′,5′,7′,-tetrachloro-4-7-dichlorofluorescein (TET).

7. The kit of claim 4 , wherein the kit comprises a probe comprising the sequence of SEQ ID NO:52 and a probe comprising the sequence of SEQ ID NO:53.

8. The kit of claim 2 , further comprising a detectably labeled probe sequence for the internal control sequence.

9. The kit of claim 8 , wherein the detectably labeled probe sequence for the internal control sequence comprises the sequence of SEQ U) NO:40.

10. The kit of claim 2 , further comprising one or more capture oligonucleotides, wherein each of the capture oligonucleotides is not more than about 60 nucleotides in length and comprises a nucleotide sequence of at least 10 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NOS:1-16, 45, 46 and 50.

11. An internal control sequence for use as a control for target capture and amplification for detecting the presence of West Nile Virus (WNV) in a biological sample, said internal control sequence comprising the nucleotide sequence of SEQ ID NO:17.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Feb 6, 2017
From: DEUTSCHE BANK AG NEW YORK BRANK
To: GRIFOLS THERAPEUTICS INC.; GRIFOLS SHARED SERVICES NORTH AMERICA INC.; GRIFOLS DIAGNOSTIC SOLUTIONS INC.
Reel/Frame 041638/0527 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME FROM GRIFOLS WORLDWIDE WAREHOUSE ANDOPERATIONS LIMITED TO GRIFOLS WORLDWIDE OPERATIONS LIMITED PREVIOUSLY RECORDED ON REEL 038979 FRAME 0981. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2016
From: GRIFOLS WORLDWIDE WAREHOUSE AND OPERATIONS LIMITED
To: GRIFOLS WORLDWIDE OPERATIONS LIMITED
Reel/Frame 039204/0082 →
ASSIGNEE CHANGE OF ADDRESS Recorded Jun 13, 2016
From: GRIFOLS WORLDWIDE WAREHOUSE AND OPERATIONS LIMITED
To: GRIFOLS WORLDWIDE WAREHOUSE AND OPERATIONS LIMITED
Reel/Frame 038979/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
To: GRIFOLS WORLDWIDE OPERATIONS LIMITED
Reel/Frame 034238/0731 →
CONFIRMATORY ASSIGNMENT Recorded Oct 2, 2014
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.; NOVARTIS AG
To: GRIFOLS WORLDWIDE OPERATIONS LIMITED
Reel/Frame 033886/0351 →
SECURITY AGREEMENT Recorded Feb 27, 2014
From: GRIFOLS INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS-CHIRON DIAGNOSTICS CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032367/0001 →
CHANGE OF NAME Recorded Jan 22, 2007
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 018839/0120 →
CHANGE OF NAME Recorded Jan 18, 2007
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 018788/0495 →